The positive association between PD-L1 expression and tumor aggressiveness has been demonstrated in numerous cancers including osteosarcoma, breast cancer, ovarian cancer, extrahepatic cholangiocarcinoma, and melanoma [46, 47]. Here, CD274 is linked to breast cancer.